These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10249123)

  • 1. Third-party reimbursement: new concepts and contemporary issues.
    Paul SH; McEvilla JD
    Med Mark Media; 1980 Oct; 15(10):58-61, 64-70. PubMed ID: 10249123
    [No Abstract]   [Full Text] [Related]  

  • 2. A fee for the service of pharmacy: the time has come.
    Tanner DJ
    Hosp Pharm; 1978 Dec; 13(12):692-3, 696. PubMed ID: 10239821
    [No Abstract]   [Full Text] [Related]  

  • 3. Economics of hospital pharmacy practice. I. Third-party reimbursement.
    Zellmer WA
    Am J Hosp Pharm; 1979 Feb; 36(2):169. PubMed ID: 420204
    [No Abstract]   [Full Text] [Related]  

  • 4. Capitation reimbursement for pharmacy services: a dissenting view.
    Gosselin RA
    Med Mark Media; 1980 Oct; 15(10):51-6. PubMed ID: 10249122
    [No Abstract]   [Full Text] [Related]  

  • 5. Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations.
    Fed Regist; 1979 Aug; 44(169):50651-6. PubMed ID: 10297564
    [No Abstract]   [Full Text] [Related]  

  • 6. Capitation payment for pharmacy services: are we ready?
    Berger BA
    Med Mark Media; 1980 Oct; 15(10):33-6. PubMed ID: 10249120
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacy services: achieving equitable reimbursement.
    Gagnon JP
    Med Mark Media; 1980 Oct; 15(10):38, 40, 42 passim. PubMed ID: 10249121
    [No Abstract]   [Full Text] [Related]  

  • 8. The tripartite reimbursement incentive model: a new method to eliminate the discounting of the copayment charge.
    Paul SH
    Med Mark Media; 1981 Mar; 16(3):35-9. PubMed ID: 10298125
    [No Abstract]   [Full Text] [Related]  

  • 9. Competitive incentive program. Analysis and proposal.
    Stone J
    Am Pharm; 1986 Jul; NS26(7):45-9. PubMed ID: 3529904
    [No Abstract]   [Full Text] [Related]  

  • 10. Can health care costs be contained? Yes, says one third party fiscal intermediary.
    Kaplan SX
    Empl Benefits J; 1978; 3(4):10-3, 15. PubMed ID: 10294880
    [No Abstract]   [Full Text] [Related]  

  • 11. Perspectives. Medicare doc pay change, big Part B premium hike on the way.
    Med Health; 2004 Mar; 58(13):1, 7-8. PubMed ID: 15088495
    [No Abstract]   [Full Text] [Related]  

  • 12. Medicaid reimbursement.
    Berry MD
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-31. PubMed ID: 18345577
    [No Abstract]   [Full Text] [Related]  

  • 13. Reimbursement of pharmaceuticals in New Zealand: comments on PHARMAC's processes.
    Swinburn B; Milne RJ; Richards M; Begg E; Foote S; Jackson R
    N Z Med J; 2000 Oct; 113(1119):425-8. PubMed ID: 11127362
    [No Abstract]   [Full Text] [Related]  

  • 14. The cost of medicine.
    Silk AD
    West J Med; 1990 Jan; 152(1):75-6. PubMed ID: 2309481
    [No Abstract]   [Full Text] [Related]  

  • 15. Reimbursement of drug cost-medical assistance program.
    Hosp Formul; 1975 Mar; 10(3):120, 122, 142. PubMed ID: 10297178
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential impact of prepayment on Medicaid drug costs.
    Yesalls CE; Norwood GJ; Lipson DP
    Contemp Pharm Pract; 1979; 2(2):87-94. PubMed ID: 10297462
    [No Abstract]   [Full Text] [Related]  

  • 17. Payers need to streamline Part D turnaround time to head off potential regulatory changes.
    Med Health; 2006 Apr; 60(15):1-2. PubMed ID: 16623183
    [No Abstract]   [Full Text] [Related]  

  • 18. Don't get trapped by PBMs' rebate labeling games.
    Cahn LJ
    Manag Care; 2009 Jan; 18(1):31-3. PubMed ID: 19186668
    [No Abstract]   [Full Text] [Related]  

  • 19. Health plans, CMS agree to reimburse States' stopgap drug coverage for dual eligibles.
    Med Health; 2006 Jan; 60(6):1, 4. PubMed ID: 16475445
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.